Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1APAP
02 1Acetaminophen
03 3Acetaminophen (API)
04 3Doliprane
05 7Ofirmev
06 5Percocet
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2019 Revenue in Millions : 353
2018 Revenue in Millions : 363
Growth (%) : -3
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 393
2019 Revenue in Millions : 392
Growth (%) : 0
Main Therapeutic Indication : Anti-Inflammatory
Currency : USD
2018 Revenue in Millions : 376
2017 Revenue in Millions : 365
Growth (%) : 3%
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 110
2019 Revenue in Millions : 116
Growth (%) : -5
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 277
2019 Revenue in Millions : 384
Growth (%) : -28
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 213
2019 Revenue in Millions : 190
Growth (%) : 12
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2021 Revenue in Millions : 216
2020 Revenue in Millions : 213
Growth (%) : 1
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2021 Revenue in Millions : 104
2020 Revenue in Millions : 110
Growth (%) : -6
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2021 Revenue in Millions : 29
2020 Revenue in Millions : 277
Growth (%) : -90
Main Therapeutic Indication : Immunology
Currency : USD
2022 Revenue in Millions : 2
2021 Revenue in Millions : 29
Growth (%) : -92
LOOKING FOR A SUPPLIER?